Angiotensin converting enzyme inhibitor captopril modifies conditioned place preference induced by morphine and morphine withdrawal signs in rats

Pathophysiology

Volumn 14, Issue 1, 2007, Pages 55-60

  Alaei, Hojjatallah ^a,b   Hosseini, Mahmood ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin II; Captopril; CPP; Morphine; Rat; Withdrawal

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MORPHINE; NALOXONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNULA; CONTROLLED STUDY; MALE; MORPHINE ADDICTION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REWARD; WITHDRAWAL SYNDROME;

EID: 34247335905     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2007.01.002     Document Type: Article

References (47)

1. Diana M., Muntoni A.L., Pistis M., Melis M., and Gessa G.L. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur. J. Neurosci. 11 3 (1999) 1037-1041
2. Wang H.L., Zhao Y., Xiang X.H., Wang H.S., and Wu W.R. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats. Prog. Neuropsychopharmacol Biol. Psychiatry 28 7 (2004) 1079-1087
3. Winnicka M.M., and Wisniewski K. Disruption of temporo-entorhinal connections abolishes the facilitatory effect of angiotensins on memory in rats. Pharmacol. Res. 40 1 (1999) 53-59
4. Winnika M.M., Braszko J.J., and Wisniewski K. 6-OHDA lesions to amygdala and hippocampus attenuate memory enhancing effect of the 3-7 fragment of angiotensin II. Gen. Pharmacol. 30 (1998) 801-805
5. Allen A.M., MacGregor D.P., McKinley M.J., and Mendelsohn F.A. Angiotensin II receptors in the human brain. Regul. Pept. 79 1 (1999) 1-7
6. Savaskan E. The role of the brain rennin-angiotensin system in neurodegenerative disorders. Curr. Alzheimer Res. 2 (2005) 29-35
7. Winnicka M.M. Dopaminergic projection to the nucleus Accumbems mediated the memory enhancing effect of angiotensins in rats. Pharmacol. Biochem. Behav. 62 4 (1999) 625-630
8. Georgiev V., Lazarova M., and Kambourova T. Further evidence for the interaction between angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice. Neuropeptides 28 (1995) 29-34
9. Gard P.R. The role of angiotensin II in cognition and behaviour. Eur. J. Pharmacol. 438 (2001) 4381-4414
10. Barnes J.M., Barnes N.M., Costall B., Horovits Z.P., Ironside J.W., Naylor R.J., and Williams T.J. Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res. 507 (1990) 341-343
11. Han N., Luo F., Bian Z., and Han J. Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induce analgesia in rats. Pain 85 (2000) 465-469
12. Georgieva D., and Gerogiev V. The role of angiotensin II and of its receptor subtypes in the acetic acid induced abdominal constriction test. Pharmacol. Biochem. Behav. 62 (1999) 229-232
13. Toma N., Sgambato V., and Counture R. Effect of angiotensin II on a spinal nociceptive reflex in the rat: receptor and mechanism of action. Life Sci. 61 (1997) 503-513
14. Tchekalarova J., Pechlivanova D., Kambourova T., Matsoukas J., and Georgiev V. The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception. Regul. Pept. 111 1-3 (2003) 191-197
15. Jenkins T.A., Mendelsohn F.A., and Chai S.Y. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J. Neurochem. 68 3 (1997) 1304-1311
16. Kaada B., and Woie L. Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level. Gen. Pharmacol. l21 5 (1990) 693-695
17. Reardon K.A., Mendelsohn F.A., Chai S.Y., and Horne M.K. The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. Aust N Z J Med 30 1 (2000) 48-53
18. Raghavendra V., Chopra K., and Kulkarni S.K. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides 35 1 (2001) 65-69
19. Nikolova J.G., Getova D.P., and Nikolov F.P. Effects of ACE-inhibitors on learning and memory processes in rats. Folia Med. (Plovdiv) 42 1 (2000) 47-51
20. Giardina W.J., and Ebert D.M. Positive effects of captopril in the behavioral despair swim test. Biol. Psychiatry 5 6 (1989) 97-702
21. Martin P., Massol J., and Puech A.J. Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats. Biol. Psychiatry 27 9 (1990) 968-974
22. Margolin A., Avants S.K., Setaro J.F., Rinder H.M.P., and Grupp L. Cocaeine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy?. Drug Alcohol Depend 61 1 (2000) 35-45
23. Alaei H., Esmaeili M., Nasimi A., and Pourshanazari A. Ascorbic acid decreases morphine self-administration and withdrawal symptoms in rats. Pathophysiology 12 2 (2005) 103-107
24. Paxinos G., and Watson C. The Rat Brain Etreotaxic Coordinates. fourth ed. (1998), Academic press, San Diego
25. Kim S.Y., Chudapongse N., Lee S.M., Levin M.C., Oh J.T., Park H.J., and Ho I.K. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res. Mol. Brain Res. 133 1 (2005) 58-70
26. Eidi M., Oryan S., Eidi A., and Sepehrara L. Effect of morphine, naloxpne and histamine system on water intake in adult male rats. Eur. J. Pharmacol. 478 (2003) 105-110
27. Gholami A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A. Nitric oxide within the ventral tegmwntal area is involved in mediating morphine reward. Eur. Pharmacol. 458 (2003) 119-128
28. Pinelli A., Trivulzio S., and Spezia R. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats. Drug Alcohol Depend. 50 1 (1998) 81-88
29. Rajaei Z., Alaei H., Nasimi A., Amini H., and Ahmadiani A. Ascorbate reduces morphine-induced extracellular DOPAC level in the nucleus accumbens: a microdialysis study in rats. Brain Res. 1053 1-2 (2005) 62-66
30. Gupta Y.K., Chugh A., Arora S., and Seth S.D. Modulation of morphine induced antinociception by intracerebroventricularly administered captopril. Indian J. Exp. Biol. 29 6 (1991) 543-545
31. Takai S., Song K., Tanaka T., Okunishi H., and Miyazaki M. Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice. Life Sci. 59 21 (1996) PL331-PL336
32. Melzig M.F., Heder G., Siems W.E., and Zipper J. Stimulation of endothelial angiotensin-converting enzyme by morphine via non-opioid receptor mediated processes. Pharmazie 53 9 (1998) 634-637
33. Yang M.M., and Kwok J.S. Evaluation on the treatment of morphine addiction by acupuncture Chinese herbs and opioid peptides. Am. J. Chin. Med. 14 1-2 (1986) 46-50
34. Sudakov S.K., Figurina I.B., Medvedeva O.F., and Rusakova I.V. Effect of substance P on intravenous self-administration of morphine in different rat strains. Bull. Exp. Biol. Med. 132 4 (2001) 923-925
35. Buccafusco J.J., Zhang L.C., Shuster L.C., Jonnala R.R., and Gattu M. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Res. 852 1 (2000) 76-83
36. Sharpe L.G., and Jaffe J.H. Captopril and capsaicin modify opioid withdrawal in the morphine-dependent rat. Pharmacol. Biochem. Behav. 33 4 (1989) 899-902
37. Koyuncuoglu H., Gungor M., Enginar N., Hatipoglu I., and Hizal A. Brain asparaginase, ACE activity and plasma cortisol level in morphine dependent rats: effect of aspartic acid and naloxone. Pharmacol. Biochem. Behav. 25 5 (1986) 953-957
38. Alaei H., Huotari M., Piepponen P.T., Ahtee L., Hanninen O., and Mannisto P.T. Morphine releases glutamate through AMPA receptors in the ventral tegmental area: amicrodialysis study in conscious Rats. Med. J. Islamic Republic Iran 17 3 (2003) 225-231
39. Sahraei H., Poorheidari G., Foadaddini M., Khoshbaten A., Asgari A., Noroozzadeh A., Ghoshooni H., Firoozabadi S.H., and Zarrindast M.R. Effects of nitric oxide on morphine self-administration in rat. Pharmacol. Biochem. Behav. 77 1 (2004) 111-116
40. Prado W.A., Pelegrini-da-Silva A., and Martins A.R. Microinjection of rennin-angiotensin system peptides in discrete sites within the rat periaqueductal gray matter elicits antinociception. Brain Res. 972 1-2 (2003) 207-215
41. Hadjiivanova C.H., and Georgiev V. In vitro effect of angiotensin II on GABA release in rat hippocampus. Neuropeptides 32 5 (1998) 431-434
42. McNally G.P., and Akil H. Selective down-regulation of hippocampal glucocorticoid receptors during opiate withdrawal. Brain Res. Mol. Brain Res. 118 1-2 (2003) 152-155
43. Dumont E.C., Rafrafi S., Lafrorest S., and Dorlet G. Involvement of central angiotensin receptors in stress adaptation. Neuroscience 93 3 (1999) 877-884
44. Raghavendra V., Chopra K., and Kulkarni S.K. Brain rennin-angiotensin system (RAS) in stress-induced analgesis and impaired retention. Peptides 20 (1999) 335-342
45. Van den Buuse M., Zheng T.W., Walker L.L., and Denton D.A. Angiotensin-converting enzyme (ACE) interacts with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice. Neurosci. Lett. 380 1-2 (2005) 6-11
46. Kurosaki R., Muramatsu Y., Kato H., Watanabe Y., Imai Y., Itoyama Y., and Araki T. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Eur. Neuropsychopharmacol. 15 1 (2005) 57-67
47. Sahraei H., Amiri Y.A., Haeri-Rohani A., Sepehri H., Salami S.H., Pourmotabbed A., Ghoshooni H., Zahirodin A., and Zardooz H. Different effects of GABAergic receptors located in the ventral tegmental area on the expression of morphine-induced conditioned place preference in rat. Eur. J. Pharmacology 524 (2005) 95-101